USDA FoodData Central lists chia seeds as a high-fiber seed
Retatrutide Research Peptide Retatrutide is a synthetic triple hormone receptor agonist peptide developed by Eli Lilly the first-in-class compound to simultaneously activate GLP-1, GIP, and glucagon receptors
J Oral Pathol Med 50(8):829840 Lapthanasupkul P, Poomsawat S, Punyasingh J (2007) A clinicopathologic study of oral leukoplakia and erythroplakia in a Thai population
Ironing-out the details: new strategies for combining ferroptosis inhibitors with immunotherapy in melanoma
Kobayashi K, Toyoda M, Tone A et al (2023) Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medication
Research also connects glutathione deficiency to cardiovascular disease, metabolic disorders, neurodegenerative conditions, and immune dysfunction